BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 161.62 |
| Open | 159.56 |
| Bid | 162.50 x 1100 |
| Ask | 163.01 x 800 |
| Day's range | 159.51 - 165.93 |
| 52-week range | 117.08 - 302.34 |
| Volume | |
| Avg. volume | 898,926 |
| Market cap | 39.468B |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | 3.99 |
| EPS (TTM) | 40.75 |
| Earnings date | 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 June 2022 |
| 1y target est | 214.66 |
- Zacks
Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants
Pfizer (PFE) and partner BioNTech seek label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in young children under five years.
- Zacks
BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics
BioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small molecule programs targeting immune modulation in cancer and other diseases. Stock up.
- Zacks
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
© 2022 Yahoo. All rights reserved.
